Cheng-Hsuan Tsai
@ChengHsuanTsai
Followers
42
Following
73
Media
3
Statuses
34
Aldosterone physiology, Hypertension and Cardiology
Boston, Tawan
Joined February 2022
Low-renin hypertension despite the use of ACE inhibitors or ARBs is almost certainly a form of primary aldosteronism. Thrilled to know that our group's work is the featured article in this month's issue of hypertension ! https://t.co/aUE6mZtf9k
@AnandVaidya17 @JeniferBrown
1
12
36
REVIEW: Debate on the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: New Blood Pressure Targets, Lower Is Better—And Possible https://t.co/izhpl4YJ10
1
77
230
The ANAH co-hosts a joint symposium with the 23rd AFES Congress, taking place this November in Vietnam, under the theme “Breaking Boundaries in Adrenal Disorders.” Join us for exciting exchange in knowledge & collaboration https://t.co/N94K79QAUE
@TroyPuar @ChengHsuanTsai
1
2
8
The October issue has been released! Make sure you check it out - along with the new High BP Guidelines - today! https://t.co/GOhzwnqiqp
0
9
20
RESEARCH ARTICLE: Cosyntropin-Stimulated Aldosterone Reserve of the Nondominant Adrenal Predicts Surgical Outcomes in Primary Aldosteronism @adina_turcu
https://t.co/Y47MEkFcr0
1
8
12
Confirmatory testing (aldosterone suppression testing) for primary aldosteronism: not reliable, or reproducible, for diagnosis or predicting lateralization. Sensitivity at the expense of specificity, and vice-versa. Time to simplify the process https://t.co/vwjCXH5Nlw
academic.oup.com
AbstractBackground. The saline suppression test (SST) and the captopril challenge test (CCT) have traditionally been used to confirm or exclude primary ald
1
10
28
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension. https://t.co/a0FTNTx1Wh
4
95
263
A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al EJE Volume 193, Issue 1, July 2025 Open access article 👉 https://t.co/rwX0dTL3OY
#endocrinology #adrenalectomy #aldosteronism
0
10
25
By linking digestion, metabolism, and cardiovascular health, #incretin-based therapies do more than just regulate blood sugar; they help reduce morbidity and mortality and are becoming a core component of modern diabetes care https://t.co/6Vaei6pUqb
#GLP-1 #GIP
0
27
76
The 2025 High Blood Pressure Guideline has been released along with many accompanying articles. Check them all out today! Guideline: https://t.co/Qg2qGwdB1m 2025 High Blood Pressure Guideline Journal Hub: https://t.co/W10odSzfkJ
3
44
77
Subclinical Primary Aldosteronism — any aldosterone produced when renin is low, even in normotensive people -- associated with incident MACE
Our new data on subclinical PA and MACE is out in Circulation! For the first time, we show that renin-independant aldosterone production is associated with an increased risk of MACE independently of BP, in people mostly normotensive with low CV risk. https://t.co/d1yBjfUQkY
0
6
35
New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic. https://t.co/eMfP6fO1mF
5
104
219
New evidence for aldosterone synthase inhibitor in primary aldosteronism!
Presented at #ENDO2025: In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results:
0
0
1
Just wrapped up an amazing trip to #ENDO2025 and the 46th IAC! So much exposure, inspiration, and great networking. Grateful for the team! @AnandVaidya17 @JeniferBrown @washingtonpost
2
2
14
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis This updated meta-analysis of RCTs demonstrated a substantial reduction in MACE, MI, ischaemic stroke, and recurrent coronary revascularization with colchicine compared with placebo.
2
22
69
The Impact of Modern Industrialized Dietary Sodium Intake on the Plasma Proteome https://t.co/on79OyG9NG
0
3
8
A pragmatic approach to evaluate for ADRENAL INSUFFICIENCY Thanks to @IrinaBancos and Jay Findling for sharing their expertise!
Adrenal insufficiency is a syndrome of cortisol deficiency. This Review summarizes the pathophysiology of adrenal insufficiency and approaches to diagnosis, treatment, and prevention of adrenal crisis. https://t.co/gA2RQPfjrW
1
6
39
In Fabry disease, age, male sex, classic phenotype, and renal failure are independent predictors of cardiac stage progression. #AHAJournals @RosaLillo14 @FGraziani_Grace
https://t.co/VyjuQi0fIn
1
11
24
Trending at https://t.co/HQyUgwV2bm: The seated saline suppression test (SSST) is associated with a high false-negative rate for the diagnosis of primary aldosteronism (PA), and reliance on it may lead to missed opportunities for intervention. https://t.co/ym6eeX58D3
0
6
5
RESEARCH ARTICLE: ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism https://t.co/OPZ2SzIPFw
0
1
2
Serum proteomic signatures raise new possibilities for distinguishing primary aldosteronism from essential hypertension! Our latest study is now published in the European Journal of Clinical Investigation! https://t.co/Kh6KJvoN3e
@AnandVaidya17 @EJCI_News
1
5
10